Literature DB >> 16169420

Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome.

Stefano Palomba1, Francesco Orio, Angela Falbo, Tiziana Russo, Achille Tolino, Fulvio Zullo.   

Abstract

In women with polycystic ovary syndrome, metformin administration, not laparoscopic ovarian drilling, reduces plasminogen activator inhibitor 1 (PAI-1) activity. The lack of a decrease in PAI-1 activity is related to a high risk for miscarriage.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16169420     DOI： 10.1016/j.fertnstert.2005.04.021

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  9 in total

Review 1.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

2.  Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.

Authors:  Xuejiao Li; Yukun Liu; Rui Zhang; Jianping Tan; Libin Chen; Yinglin Liu
Journal:  Med Sci Monit       Date:  2015-04-11

Review 3.  Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.

Authors:  Yao Ye; Aurelia Vattai; Xi Zhang; Junyan Zhu; Christian J Thaler; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Int J Mol Sci       Date:  2017-07-29       Impact factor: 5.923

4.  Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility.

Authors:  M F Costello; M L Misso; A Balen; J Boyle; L Devoto; R M Garad; R Hart; L Johnson; C Jordan; R S Legro; R J Norman; E Mocanu; J Qiao; R J Rodgers; L Rombauts; E C Tassone; S Thangaratinam; E Vanky; H J Teede
Journal:  Hum Reprod Open       Date:  2019-01-04

5.  Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance.

Authors:  Pratip Chakraborty; S K Goswami; Shweta Rajani; Sunita Sharma; Syed N Kabir; Baidyanath Chakravarty; Kuladip Jana
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

6.  Pregnancy in polycystic ovary syndrome.

Authors:  Sadishkumar Kamalanathan; Jaya Prakash Sahoo; Thozhukat Sathyapalan
Journal:  Indian J Endocrinol Metab       Date:  2013-01

7.  Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome.

Authors:  Esmée M Bordewijk; Ka Ying Bonnie Ng; Lidija Rakic; Ben Willem J Mol; Julie Brown; Tineke J Crawford; Madelon van Wely
Journal:  Cochrane Database Syst Rev       Date:  2020-02-11

8.  High fasting insulin levels and insulin resistance may be linked to idiopathic recurrent pregnancy loss: a case-control study.

Authors:  Corina-Alina Ispasoiu; Radu Chicea; Florin Vasile Stamatian; Florin Ispasoiu
Journal:  Int J Endocrinol       Date:  2013-11-25       Impact factor: 3.257

9.  Preliminary Results for Personalized Therapy in Pregnant Women with Polycystic Ovary Syndrome During the COVID-19 Pandemic.

Authors:  Małgorzata Jerzak; Monika Szafarowska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-03-24       Impact factor: 3.831
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.